ADPROTECH LIMITED

ADPROTECH

Pharmaceutical preparations, protein therapeutic agents, prodrugs and polypeptides for the treatment of cardiovascular system diseases, autoimmune and inflammatory disorders, infectious diseases, neurological disorders, post-ischemic reperfusion conditions and cancer, and in organ transplantation; veterinary preparations, protein therapeutic agents, prodrugs and ploypeptides for the treatment of cardiovascular system diseases, autoimmune and inflammatory disorders, infectious diseases, neurological disorders, post-ischemic reperfusion conditions and cancer, and in organ transplantation, for use in domestic animals and livestock; immunotherapeutic agents for the treatment of autoimmune and inflammatory disorders, infectious diseases and cancer, for use in humans and domestic animals and livestock; vaccine molecular adjuvants;Medical and veterinary apparatus and instruments, namely, depot devices for the delivery of drugs and vaccine adjuvants, syringes, and catheters; drug delivery systems consisting primarily of implant devices for the delivery of drugs and vaccine adjuvants, depot devices for the delivery of drugs and vaccine adjuvants, syringes, catheters, and vaccine adjuvants;Biotechnology product research and development; product development for others in the chemical, medical and veterinary fields; product research and development relating to modification of pharmaceutically useful molecules, protein therapeutic agents, immunotherapeutic agents, prodrugs, polypeptides or molecular adjuvants; technical consultation services relating to biotechnology, modification of pharmaceutically useful molecules, protein therapeutic agents, immunotherapeutic agents, prodrugs, polypeptides or molecular adjuvants;

IMMUDAPTIN

Pharmaceuticals, namely immunotherapeutic agents for the treatment of infectious diseases including viral, bacterial and parasitic infections such as malaria, inflammatory and autoimmune diseases including arthritis, psoriasis and vasculitis and reperfusion injury, cardiovascular diseases including atherosclerosis and stroke, neurodegenerative disorders such as Alzheimer's disease and metabolic diseases such as diabetes; pharmaceuticals, namely polypeptides for the treatment of the aforesaid diseases and disorders; pharmaceuticals, namely vaccines incorporating molecular adjuvants for the prevention and treatment of the aforesaid diseases, disorders and cancer; veterinary preparations for the treatment of infectious and parasitic diseases inflammatory diseases and cancer in pets and infectious and parasitic diseases in livestock;Medical and scientific research services relating to discovery, development or improvement of chemical, medical and veterinary preparations; medical and scientific research services relating to modification of pharmaceutically useful molecules, protein therapeutic agents and polypeptides, immunotherapeutic agents, molecular adjuvants and vaccines;